New diagnostic tools using reagent-less sensors and smart spectroscopy
Optofluidic diagnostic device using AI to analyze blood samples' optical signatures for early cancer detection, including hard-to-diagnose cancers like ovarian cancer. This miniature sensor combines optical guides and fluidics to analyze biomarkers without reagents, enabling more effective diagnoses.
Optofluidic device as a diagnostic tool using artificial intelligence (AI) algorithms to analyze the optical signature of blood samples. The product will be a highly miniature sensor, incorporating optical guides and fluidics, allowing the analysis of biomarkers without the use of reagents, using the combination of different optical signals, for a more effective diagnosis of various types of cancer that are currently extremely difficult to diagnose early, namely ovarian cancer.Optofluidic device as a diagnostic tool using artificial intelligence (AI) algorithms to analyze the optical signature of blood samples. The product will be a highly miniature sensor, incorporating optical guides and fluidics, allowing the analysis of biomarkers without the use of reagents, using the combination of different optical signals, for a more effective diagnosis of various types of cancer that are currently extremely difficult to diagnose early, namely ovarian cancer.